Description

n-(2,5-Dichlorophenyl)-4-(Furan-2-Yl)-2-Methyl-5-Oxo-4,6,7,8-Tetrahydro-1H-Quinoline-3-Carboxamide is a high-purity, advanced pharmaceutical intermediate designed for research and development in medicinal chemistry. This compound is valued for its complex heterocyclic structure, which serves as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs). It is primarily targeted at pharmaceutical R&D laboratories and fine chemical manufacturers engaged in developing new therapeutic agents, particularly in areas requiring specialized quinoline and furan-based scaffolds.

Application

• Pharmaceutical Intermediate: A key precursor in the research and synthesis of novel drug candidates targeting various disease pathways.
• Medicinal Chemistry Research: Used as a core scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Fine Chemical Synthesis: Serves as a specialized building block for constructing complex heterocyclic molecules in custom synthesis projects.
• API Development: Employed in the development and scale-up processes for new Active Pharmaceutical Ingredients (APIs).
• Biochemical Research: Potential use as a tool compound or probe in biochemical assays to study enzyme inhibition or receptor interactions.
• Academic Research: Utilized in university and institutional laboratories for advanced organic synthesis and methodological studies.

Basic Information

Product Name	n-(2,5-Dichlorophenyl)-4-(Furan-2-Yl)-2-Methyl-5-Oxo-4,6,7,8-Tetrahydro-1H-Quinoline-3-Carboxamide
CAS No.	1798310-55-0
Molecular Formula	C21H16Cl2N2O3
Molecular Weight	415.27 g/mol
Synonyms	4-(Furan-2-yl)-2-methyl-5-oxo-N-(2,5-dichlorophenyl)-4,6,7,8-tetrahydro-1H-quinoline-3-carboxamide; 1H-Quinoline-3-carboxamide, 4-(2-furanyl)-N-(2,5-dichlorophenyl)-4,6,7,8-tetrahydro-2-methyl-5-oxo-; 1798310-55-0; 4-(Furan-2-yl)-N-(2,5-dichlorophenyl)-2-methyl-5-oxo-1,4,6,7,8,8a-hexahydroquinoline-3-carboxamide
EINECS	Contact for details

Quality Control

Our n-(2,5-Dichlorophenyl)-4-(Furan-2-Yl)-2-Methyl-5-Oxo-4,6,7,8-Tetrahydro-1H-Quinoline-3-Carboxamide is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the high standards required for pharmaceutical R&D. Certificates of Analysis (COA) detailing batch-specific results are available upon request, providing full traceability and compliance data.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep away from incompatible materials. For long-term storage, consider storing under an inert atmosphere to maintain stability.

Specification

Item	Specification
Appearance	Off-white to light yellow powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.